Cat. No. | Product name | CAS No. |
DC11854 |
IDX899
A novel potent, selective HIV non-nucleoside reverse transcriptase inhibitor (NNRTI) with EC50 of 1, 1.3, 2.8 and 11 nM for WT, K103N, Y181C and K103N/Y181C, respectively. |
1018450-26-4 |
DC9029 |
Abacavir
Abacavir is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. |
136470-78-5 |
DC7058 |
Amprenavir
Featured
Amprenavir (Agenerase) is a HIV protease inhibitor(Ki=0.6 nM) used to treat HIV infection. |
161814-49-9 |
DC3150 |
Atazanavir
Featured
Atazanavir is a HIV protease inhibitor with Ki of 2.66 nM. |
198904-31-3 |
DC9480 |
Atazanavir (sulfate)
Atazanavir sulfate is a sulfate salt form of atazanavir that is an highly potent HIV-1 protease inhibitor. |
229975-97-7 |
DC10890 |
Bictegravir
Featured
Bictegravir is a novel, potent inhibitor of HIV-1 integrase with an IC50 of 7.5 nM. |
1611493-60-7 |
DC9700 |
BMS-707035
Featured
BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity. |
729607-74-3 |
DC2046 |
Cobicistat (GS-9350)
Featured
Cobicistat (GS-9350) is a potent and selective inhibitor of CYP3A with IC50 of 30-285 nM. |
1004316-88-4 |
DC8908 |
Darunavir ethanolate
Featured
Darunavir ethanolate is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2). |
635728-49-3 |
DC11352 |
Delavirdine (mesylate)
Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that selectively inhibits HIV-1 reverse transcriptase over DNA polymerase α and δ in vitro (IC50s = 0.26, 440, and >550 μM, respectively). |
147221-93-0 |
DC8897 |
Delavirdine
Delavirdine(U 90152) is a potent non-nucleoside reverse transcriptase inhibitor (NNRTI). |
136817-59-9 |
DC7273 |
Dolutegravir
Featured
Dolutegravir (DTG, GSK1349572) is an integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H. |
1051375-16-6 |
DC10250 |
Dolutegravir Sodium
Featured
Dolutegravir is a HIV integrase inhibitor with IC50 of 2.7 nM. |
1051375-19-9 |
DC9308 |
Doravirine (MK-1439)
Featured
Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor. |
1338225-97-0 |
DCAPI1479 |
Efavirenz
Efavirenz is a nonnucleoside HIV-1 reverse transcriptase (RT) inhibitor which selectively inhibits the glucuronidation of 3'-Azido-3'-deoxythymidine β-D-glucuronide, Sodium Salt. Studies suggest that Efavirenz binds to a distinct site of reverse transcrip |
154598-52-4 |
DC5902 |
Emtricitabine
Featured
Emtricitabine is a nucleoside analogue which inhibits the reverse nucleoside transcriptase enzyme. Structurally this antiviral agent is similar to Lamivudine. This agent is effective at targeting HIV and HBV viruses since these viruses replicate in a reve |
143491-57-0 |
DC4234 |
Etravirine
Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1). |
269055-15-4 |
DCAPI1505 |
Darunavir
Featured
Darunavir(TMC114) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2) . |
206361-99-1 |
DC9476 |
NBD-556
Featured
NBD-556 is small molecule mimetic of CD4, NBD-556 recognizes the HIV-1 envelope protein gp120 and induces restructuring of gp120 analogous to CD4 binding. |
333353-44-9 |
DC9477 |
NBD-557
NBD-557 is a potentially HIV-1 inhibitor. |
333352-59-3 |
DC10355 |
Nelfinavir
Featured
Nelfinavir(AG-1341) is a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor (Ki=2 nM) and is widely prescribed in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection. |
159989-64-7 |
DC9474 |
Nelfinavir (Mesylate)
Nelfinavir(AG-1341) is a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor (Ki=2 nM) and is widely prescribed in combination with HIV reverse transcriptase inhibitors for the treatment of HIV infection. |
159989-65-8 |
DC9019 |
Nevirapine
Nevirapine is a potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of HIV-1 infection and AIDS. |
129618-40-2 |
DC9479 |
Raltegravir (potassium salt)
Raltegravir potassium salt(MK0518 potassium salt) is a potent integrase (IN) inhibitor, used to treat HIV infection. |
871038-72-1 |
DCAPI1581 |
Raltegravir
Featured
Raltegravir Salt is a potent human immunodeficiency virus (HIV) integrase inhibitor and a novel anti-AIDS drug. |
518048-05-0 |
DC7266 |
Rilpivirine(R 278474, TMC 278)
Featured
Rilpivirine(R 278474, TMC 278) is a type of anti-HIV medicine called a non-nucleoside reverse transcriptase inhibitor (NNRTI). |
500287-72-9 |
DC9475 |
Ritonavir
Featured
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS,showed potent activity against COVID-19(SARS-COV-2) . |
155213-67-5 |
DC8627 |
Saquinavir
Featured
Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy. |
127779-20-8 |
DC8628 |
Saquinavir Mesylate
Featured
Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy. |
149845-06-7 |
DC9864 |
Azidothymidine (AZT)
Selective reverse transcriptase inhibitor. Exhibits 100-fold selectivity for HIV reverse transcriptase over DNA polymerase α. |
30516-87-1 |
DC11397 |
TAK-779
Featured
TAK-779 is a potent and selective nonpeptide antagonist of CCR5 and CXCR3, with a Ki of 1.1 nM for CCR5, and effectively and selectively inhibits R5 HIV-1, with EC50 and EC90 of 1.2 nM and 5.7 nM, respectively, in MAGI-CCR5 cells. |
229005-80-5 |
DC7336 |
Vicriviroc maleate(Sch-417690)
Featured
Vicriviroc Malate is a potent CKR-5 (CCR5) antagonist with IC50 of 0.91 nM. |
599179-03-0 |
DC7421 |
GO 6976
Featured
Go6976 is a potent PKC inhibitor with IC50 of 7.9 nM, 2.3 nM, and 6.2 nM for PKC (Rat brain), PKCα, and PKCβ1, respectively. Also a potent inhibitor of JAK2 and Flt3. |
136194-77-9 |